Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 00:00 | 05 Jul | 65.85 |
1.55 (2.41%) |
OPEN
65.75 |
HIGH
66.75 |
LOW
64.80 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 65.75 |
| PREVIOUS CLOSE | 64.30 |
| VOLUME | 1678 |
| 52-Week high | 86.00 |
| 52-Week low | 43.35 |
| P/E | 36.58 |
| Mkt Cap.(Rs cr) | 58 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 533.30 | 4.65 | 0.88 | 3112.91 |
| Cipla | 937.70 | 7.35 | 0.79 | 2468.28 |
| Dr Reddy's Labs | 4389.45 | 23.75 | 0.54 | 2186.40 |
| Sun Pharma.Inds. | 835.55 | 6.85 | 0.83 | 2139.70 |
| Divi's Lab. | 3610.35 | -28.05 | -0.77 | 1954.72 |
| Glaxosmi. Pharma | 1541.40 | 9.75 | 0.64 | 1690.53 |
| Alkem Lab | 3050.40 | 10.05 | 0.33 | 1685.08 |
| Glenmark Pharma. | 381.30 | -5.65 | -1.46 | 1649.45 |
| Zydus Lifesci. | 361.35 | 1.30 | 0.36 | 1476.20 |
| Lupin | 627.40 | -1.35 | -0.21 | 1258.62 |
| Alembic Pharma | 722.85 | -6.20 | -0.85 | 1175.39 |
| Ipca Labs. | 927.90 | 9.60 | 1.05 | 1140.77 |
| Torrent Pharma. | 2891.85 | -13.00 | -0.45 | 1137.85 |
| Gland Pharma | 2530.00 | -62.55 | -2.41 | 997.01 |
| Sanofi India | 6443.65 | 60.95 | 0.95 | 944.40 |
| Laurus Labs | 463.30 | -5.60 | -1.19 | 750.09 |
| Abbott India | 18630.80 | -309.30 | -1.63 | 690.69 |
| Ajanta Pharma | 1219.60 | -15.55 | -1.26 | 675.64 |
| Wockhardt | 205.70 | -1.45 | -0.70 | 593.29 |
| Granules India | 277.35 | -2.95 | -1.05 | 552.78 |
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
